In the News: April 12–19
By Sg2 TeamThis week: CMS final rule lets states define essential health benefits; health system expansion may result in patient safety risks; and the FDA approves the first autonomous AI medical device
- Share
This week: CMS final rule lets states define essential health benefits; health system expansion may result in patient safety risks; and the FDA approves the first autonomous AI medical device
This week: association of neighborhoods with pediatric acute care; treatment costs of antibiotic-resistant infections; and meal-delivery programs and Medicare/Medicaid dual eligible health care utilization
This week: US county differences in infectious disease mortality; a short-term care pilot program for addiction in Baltimore; and strong growth in urgent care center, retail clinic and telehealth claims
This week: The utility of wearables for cardiac patients, physician group acquisitions by insurers due to Medicare Advantage and youth suicide rates
This week: Hospitals continue to rapidly acquire physician groups; the potential impact of precision medicine partnerships; and 3-year results from Maryland’s all-payer hospital model
This week: The value of minimally invasive surgery in the Medicare population; an insurer’s new payment policy for ED claims; and hospital-at-home programs
This week: The impact of policy changes on coverage and premiums, a Colorado ED collaborative reduces opioid use in pain management, and Uber launches a medical transportation service
This week: Urgent care industry growth, midwife integration and quality outcomes, and microhospitals and the shift to ambulatory care
mHealth apps have been shown to increase patient participation in clinical trials, yet many life science organizations have been reluctant to adopt them. This reluctance persists, despite a survey showing...
This week: Rural broadband connectivity and cancer care; national health expenditure projections; and the rising costs of the opioid epidemic.
“Digiceuticals” Are Gaining Steam For several months now, the FDA has been approving mHealth apps (also known as digital therapeutics or “digiceuticals”) to treat everything from diabetes to substance abuse....
This week: Virtual health reimbursement legislation, depression treatment initiation and primary care, and rapid adoption of hospital-based palliative care programs
This week: Asthma mortality and care management; Amazon, JP Morgan and Berkshire Hathaway’s health care company; and payment rate increases for Medicare Advantage plans
AliveCor recently released the results of several studies of their smartphone enabled ECG, Kardia Mobile. The studies demonstrated the technologies’ capabilities to detect atrial fibrillation (AFib). One of the studies,...
Despite significant progress in regards to virtual health reimbursement, substantial improvements remain necessary. According to a recent study by the Center for Connected Health Policy, current private parity laws give...
As virtual health has continued to gain traction the market and become increasingly a mainstream modality of care delivery, many have pointed toward Mississippi as an example of how virtual...
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."